Stem Cell
Research Areas
Products Related to Stem Cell(471)
- GC79521CAD204520 dihydrochlorideCAS: 2682205-21-4Purity: >99.00%
CAD204520 dihydrochloride, a SERCA inhibitor ( IC 50 = 0.34 μM), targets mutated over wild type NOTCH1 proteins in T-cell acute lymphoblastic leukemia (T-ALL) and mantle cell lymphoma (MCL).
- GC79757ALOX5 stabilizer-1 TFAPurity: >98.00%
ALOX5 stabilizer-1 TFA is an arachidonate 5-lipoxygenase ( ALOX5 ) stabilizer with a K d of 7.26 μM.
- GC79758PAI-1-IN-1CAS: 1247823-40-0Purity: >99.00%
PAI-1-IN-1 is an orally active and specific PAI-1 inhibitor with an IC 50 of <6.95 μM.
- GC79759SkQR1 hydroxideCAS: 1333381-77-3Purity: >98%
SkQR1 hydroxide is a mitochondrial targeted antioxidant.
- GC79816CryptolepineCAS: 480-26-2Purity: >98%
Cryptolepine is an orally active multi-potent alkaloid with anti-cancer, anti-bacterial, anti-viral, anti-malarial, anti-inflammatory, anti-hyperglycemic, relieve pain and other properties.
- GC80873Tovophyllin ACAS: 40738-44-1Purity: >98%
Tovophyllin A is an orally active xanthonoid compound.
- GC81335MST3-IN-1 TFAPurity: >99.00%
MST3-IN-1 TFA (Compound LD-1) is a selective and orally active MST3 inhibitor, with an IC 50 of 122.4 nM.
- GC81339Taladegib hydrochlorideCAS: 1258861-21-0Purity: >97.00%
Taladegib (LY2940680) hydrochloride is a Smoothened ( SMO ) antagonist.
- GC81340WAY-362692CAS: 915763-27-8Purity: >99.50%
WAY-362692 is a secreted frizzled-related protein ( sFRP-1 ) inhibitor ( IC 50 of 0.02 μM), targeting the netrin domain of sFRP-1.
- GC81344RemigromigCAS: 3059389-31-7Purity: >95.00%
Remigromig (EYE-103; MK-3000) is a humanized dual-target monoclonal antibody that targets LRP5 and FZD4.
- GC81347YAP/TEAD-IN-2CAS: 2957895-40-6Purity: >95.00%
YAP/TEAD-IN-2 (Compound T-1) is a YAP/TEAD inhibitor.
- GC81349(R,S)-YAP-TEAD-IN-2Purity: >98.00%
(R,S)-YAP-TEAD-IN-2 is the racemic mixture of YAP-TEAD-IN-2.
- GC81456ZocilurtatugCAS: 3058592-86-9Purity: >99.50%
Zocilurtatug (ZL-1310 Antibody) is a human monoclonal antibody targeting DLL3.
- GC81608SGC-CK1γ-1CAS: 3125107-49-2Purity: >99.00%
SGC-CK1γ-1 is a potent and selective probe for the CK1γ subfamily.
- GC81628Nicotinamide- 13 C, 15 NPurity: >98.50%
Nicotinamide - 13 C, 15 N (Niacinamide- 13 C, 15 N) is the 13 C- and 15 N-labeled Nicotinamide.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79246 | RMC-9945 | 2922732-38-3 | >98.00% | |
RMC-9945 (RM-044) is a selective, covalent, and orally active RAS (ON) G12D inhibitor. | ||||
| GC79521 | CAD204520 dihydrochloride | 2682205-21-4 | >99.00% | |
CAD204520 dihydrochloride, a SERCA inhibitor ( IC 50 = 0.34 μM), targets mutated over wild type NOTCH1 proteins in T-cell acute lymphoblastic leukemia (T-ALL) and mantle cell lymphoma (MCL). | ||||
| GC79549 | FJ9 | 873841-43-1 | >98.50% | |
FJ9 is a NHERF1/PDZ inhibitor with human NHERF1 PDZ1 IC 50 1540 μM, NHERF1 PDZ2 IC 50 160 μM, and Frizzled-7-Dishevelled PDZ complex K i 10 μM. | ||||
| GC79757 | ALOX5 stabilizer-1 TFA | - | >98.00% | |
ALOX5 stabilizer-1 TFA is an arachidonate 5-lipoxygenase ( ALOX5 ) stabilizer with a K d of 7.26 μM. | ||||
| GC79758 | PAI-1-IN-1 | 1247823-40-0 | >99.00% | |
PAI-1-IN-1 is an orally active and specific PAI-1 inhibitor with an IC 50 of <6.95 μM. | ||||
| GC79759 | SkQR1 hydroxide | 1333381-77-3 | >98% | |
SkQR1 hydroxide is a mitochondrial targeted antioxidant. | ||||
| GC79816 | Cryptolepine | 480-26-2 | >98% | |
Cryptolepine is an orally active multi-potent alkaloid with anti-cancer, anti-bacterial, anti-viral, anti-malarial, anti-inflammatory, anti-hyperglycemic, relieve pain and other properties. | ||||
| GC80870 | XL-418 | 871343-09-8 | >95.00% | |
XL-418 is an orally active dual Akt and p70S6K inhibitor with IC 50 s of 1 nM for Akt1 and 2 nM for p70S6K. | ||||
| GC80873 | Tovophyllin A | 40738-44-1 | >98% | |
Tovophyllin A is an orally active xanthonoid compound. | ||||
| GC80874 | ARN25699 | - | >98% | |
ARN25699 is a kinase inhibitor with an IC 50 of 5.5 nM against GSK-3β, 2.2 nM against FYN-α, and 242.3 nM against DYRK1A, and it exhibits oral bioavailability. | ||||
| GC81335 | MST3-IN-1 TFA | - | >99.00% | |
MST3-IN-1 TFA (Compound LD-1) is a selective and orally active MST3 inhibitor, with an IC 50 of 122.4 nM. | ||||
| GC81336 | KY19334 | 2319609-67-9 | >99.50% | |
KY19334 is a CXXC5-DVL inhibitor. | ||||
| GC81337 | MR24 TFA | - | >99.00% | |
MR24 TFA, a G-5555 derivative, is a mammalian STE20-like ( MST ) kinase inhibitor. | ||||
| GC81339 | Taladegib hydrochloride | 1258861-21-0 | >97.00% | |
Taladegib (LY2940680) hydrochloride is a Smoothened ( SMO ) antagonist. | ||||
| GC81340 | WAY-362692 | 915763-27-8 | >99.50% | |
WAY-362692 is a secreted frizzled-related protein ( sFRP-1 ) inhibitor ( IC 50 of 0.02 μM), targeting the netrin domain of sFRP-1. | ||||
| GC81344 | Remigromig | 3059389-31-7 | >95.00% | |
Remigromig (EYE-103; MK-3000) is a humanized dual-target monoclonal antibody that targets LRP5 and FZD4. | ||||
| GC81345 | Evabosmig | 3061142-96-6 | >97.50% | |
Evabosmig (AGA2118) is a humanized bispecific monoclonal antibody targeting sclerostin ( SOST/sclerostin ) and DKK1. | ||||
| GC81346 | SNX3-IN-1 | 2344793-72-0 | >98.00% | |
SNX3-IN-1 is a sorting nexin 3 (SNX3) inhibitor. | ||||
| GC81347 | YAP/TEAD-IN-2 | 2957895-40-6 | >95.00% | |
YAP/TEAD-IN-2 (Compound T-1) is a YAP/TEAD inhibitor. | ||||
| GC81348 | SLD1121 | 2759011-75-9 | >99.50% | |
SLD1121 is an agonist of the Wnt/β-catenin signaling pathway that enhances Wnt signaling by targeting LRP6 ( K d: 4.52-7.49 nM). | ||||
| GC81349 | (R,S)-YAP-TEAD-IN-2 | - | >98.00% | |
(R,S)-YAP-TEAD-IN-2 is the racemic mixture of YAP-TEAD-IN-2. | ||||
| GC81456 | Zocilurtatug | 3058592-86-9 | >99.50% | |
Zocilurtatug (ZL-1310 Antibody) is a human monoclonal antibody targeting DLL3. | ||||
| GC81608 | SGC-CK1γ-1 | 3125107-49-2 | >99.00% | |
SGC-CK1γ-1 is a potent and selective probe for the CK1γ subfamily. | ||||
| GC81628 | Nicotinamide- 13 C, 15 N | - | >98.50% | |
Nicotinamide - 13 C, 15 N (Niacinamide- 13 C, 15 N) is the 13 C- and 15 N-labeled Nicotinamide. | ||||
